Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,733,918 papers from all fields of science
Search
Sign In
Create Free Account
Systemic Scleroderma
Known as:
Systemic sclerosis
, Diffuse Scleroderma
, SSc, Diffuse Sclerosis
Expand
A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
28 relations
Autoantibodies
CREST Syndrome
Chloroquine
Chloroquine hydrochloride
Expand
Narrower (2)
Juvenile-onset scleroderma
renal scleroderma
Broader (1)
Scleroderma
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Layer-by-layer coating of degradable microgels for pulsed drug delivery.
B. D. Geest
,
C. Déjugnat
,
+7 authors
S. D. Smedt
Journal of Controlled Release
2006
Corpus ID: 36278189
Highly Cited
2006
Highly Cited
2006
Surface modification of multiwalled carbon nanotubes via nitroxide‐mediated radical polymerization
Xiao-Dong Zhao
,
Xinghe Fan
,
Xiaofang Chen
,
C. Chai
,
Qifeng Zhou
2006
Corpus ID: 35920251
The nitroxide-mediated radical polymerization of styrene was carried out on the surfaces of multiwalled carbon nanotubes (MWNTs…
Expand
Review
1995
Review
1995
Regulation of connective tissue synthesis in systemic sclerosis.
J. Varga
,
R. Bashey
International Reviews of Immunology
1995
Corpus ID: 23208551
Excessive connective tissue deposition in the skin and other organs is the pathologic hallmark of systemic sclerosis (SSc), and…
Expand
Highly Cited
1994
Highly Cited
1994
Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis.
Ariane L. Herrick
,
F. Rieley
,
David Schofield
,
Sally Hollis
,
Joan M. Braganza
,
Malcolm I. V. Jayson
Journal of Rheumatology
1994
Corpus ID: 27890328
OBJECTIVE To investigate the possibility that micronutrient antioxidant status is an important factor in determining the severity…
Expand
Review
1993
Review
1993
Autoantibodies in Scleroderma
M. Fritzler
Journal of dermatology (Print)
1993
Corpus ID: 924958
Autoantibodies directed against nuclear, nucleolar, and a number of cytoplasmic components are described in the sera of…
Expand
Review
1992
Review
1992
A brief overview of the pathogenesis of scleroderma (systemic sclerosis).
E. Leroy
Annals of the Rheumatic Diseases
1992
Corpus ID: 3008370
Although definitive answers are not yet forthcoming, understanding the mechanisms of fibrosis in scleroderma might improve the…
Expand
Highly Cited
1983
Highly Cited
1983
Antibodies to SM and RNP
E. F. Munves
,
P. Schur
1983
Corpus ID: 72045443
The charts of 150 consecutive patients found to have antibodies to Sm, ribonucleoprotein (RNP), or both were examined to…
Expand
Review
1980
Review
1980
A histologic evaluation of mixed connective tissue disease in childhood.
B. Singsen
,
V. Swanson
,
B. Bernstein
,
E. Heuser
,
V. Hanson
,
B. Landing
American Journal of Medicine
1980
Corpus ID: 33526769
Review
1978
Review
1978
Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma).
Robert B. Buckingham
,
Prince Rk
,
Gerald P. Rodnan
,
Floyd Taylor
Journal of Laboratory and Clinical Medicine
1978
Corpus ID: 13405573
Abstract Fibroblast monolayers were established by explant culture of dermis from patients with PSS and from normal individuals…
Expand
Highly Cited
1978
Highly Cited
1978
The kidney in progressive systemic sclerosis: a prospective study.
M. T. Kovalchik
,
S. Guggenheim
,
M. Silverman
,
J. S. Robertson
,
J. Steigerwald
Annals of Internal Medicine
1978
Corpus ID: 25549009
Nine normotensive progressive systemic sclerosis patients with normal renal function underwent renal biopsy. Four specimens had…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE